Posted on January 12, 2021 by Aaron Warwick
Milestone Scientific (MLSS), a developer of computerized drug delivery instruments, announced its second commercial deal with a hospital, this time winning the business of Regional Medical Center, a regional healthcare system in South Carolina. This, of course, follows yesterday’s announcement of a distribution deal in Switzerland and Austria, and the announcement just a week ago of MLSS’s first official customer win for its medical products in a deal with the University of Texas Medical Branch in Galveston. Besides providing further validation of the marketplace’s growing acceptance of MLSS’s revolutionary CompuFlo and CathCheck products and disposables, the company’s press release today provided a few other valuable pieces of information.
Specifically, CEO Leonard Osser pointed out that MLSS’s “sales pipeline, including advanced trials underway, is more robust than at any time in the Company’s history.” In addition, Osser noted: “A key element of our strategy is to focus our sales strategy around the disposable components of our system, which we believe will contribute to high margin, recurring revenue.” This approach seems to bode well for the company’s future, as MLSS’s approach should soon drive both top and bottom line growth.
Disclosure: I am long MLSS and may buy or sell at any time.